These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3844465)

  • 1. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoelectrophoretic studies of prekallikrein in human plasma.
    Hathaway WE; Christian J; McGregor R; Borden C
    Thromb Res; 1982 Feb; 25(3):267-75. PubMed ID: 6917563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H
    Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contact coagulation factors].
    Kojima T; Saito H
    Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B; Tran TH; Ritz R; Duckert F
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinin-forming enzyme system in pregnancy and obstetrical DIC.
    Maki M; Soga K; Gotoh K
    Bibl Haematol; 1983; (49):239-46. PubMed ID: 6421272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay methods for prekallikrein and kininogens and their applications.
    Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J
    Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients.
    Kalter ES; Vlooswijk RA; Bouma BN
    Acta Chir Scand Suppl; 1982; 509():43-7. PubMed ID: 6962618
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 17. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
    Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.